Overview
- 134 inspections across 133 sites are on record.
- 122 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-11-13.
At a glance
Inspections
134
Sites
133
Observations
122
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| IDO PHARM | 13 Nov 2025 | Human Drugs | On file |
| CKD Bio Corporation | 7 Nov 2025 | Human Drugs | |
| PicoBio Co., Ltd. | 31 Oct 2025 | Human Drugs | |
| Laboratoire Schmidt-Nagel Inc. | 15 Aug 2025 | Human Drugs | |
| Abbott Laboratories Co. (Laboratoires Abbott CIE) | 8 Aug 2025 | Human Drugs |
Sites inspected
IDO PHARMAnsan, Korea (the Republic of)1 insp.
CKD Bio CorporationAnsan, Korea (the Republic of)1 insp.
PicoBio Co., Ltd.Jangsu, Korea (the Republic of)1 insp.
Laboratoire Schmidt-Nagel Inc.Quebec, Canada1 insp.
Abbott Laboratories Co. (Laboratoires Abbott CIE)Victoriaville, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Jose A Cruz Gonzalez6 shared
Marie F Morin6 shared
Santos E Camara3 shared
Deyaa Shaheen3 shared
Matthew B Casale3 shared
Carmelo Rosa3 shared
Wayne D Mcgrath2 shared
Laurimer Kuilan-Torres2 shared
Stefanie L Heckman2 shared
Libia M Lugo2 shared
Full investigator report
Get the verbatim findings behind Dennis Cantellops Paite's 122 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site